Eribulin Mesylate and its Impurities

Eribulin Mesylate, sold under the brand name Halaven, is an anticancer medication used to treat breast cancer and liposarcoma. Reference standards of Eribulin Mesylate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 7 results for Eribulin Mesylate Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 05 1810000

Eribulin Mesylate

Eribulin Mesylate


  • Catalogue No.:PA 05 1810000

  • CAS :

    441045-17-6

  • Molecular Formula : C41H63NO14S

  • Molecular Weight : 826.01

Drug Reference Standards & Impurity Synthesis in India
PA 05 1811000

(1R,3S,8S,11S,14S,16R,18R,20S,22R,23R,24S,28R,31S,33S,34R,35S,37S)-22-[(2S)-3-Amino-2-hydroxypropyl]-34,37-dihydroxy-23-methoxy-16-methyl-10,17-dimethylidene2,21,32,36,38,39-hexaoxaheptacyclo[26.6.2.13,33.18,11.114,18.020,24.031,35 ]nonatriacontane-5,26-dione

(1R,3S,8S,11S,14S,16R,18R,20S,22R,23R,24S,28R,31S,33S,34R,35S,37S)-22-[(2S)-3-Amino-2-hydroxypropyl]-34,37-dihydroxy-23-methoxy-16-methyl-10,17-dimethylidene2,21,32,36,38,39-hexaoxaheptacyclo[26.6.2.13,33.18,11.114,18.020,24.031,35 ]nonatriacontane-5,26-dione


  • Catalogue No.:PA 05 1811000

  • CAS :

    NA

  • Molecular Formula : C40H61NO12

  • Molecular Weight : 747.92

Drug Reference Standards & Impurity Synthesis in India
PA 05 1811001

7,11:10,14:13,16:21,24:27,31-Pentaepoxy-2H-cyclohentriaconta[b]furan-5,18(3H,4H)-dione, 2-[(2S)-3-amino-2-hydroxypropyl]octacosahydro-12,15-dihydroxy-3-methoxy-29-methyl-23,30-bis(methylene)-, (2R,3R,3aS,7R,10S,11R,12S,13S,14S,15S,16R,21S,24S,27S,29R,31R,32aS)

7,11:10,14:13,16:21,24:27,31-Pentaepoxy-2H-cyclohentriaconta[b]furan-5,18(3H,4H)-dione, 2-[(2S)-3-amino-2-hydroxypropyl]octacosahydro-12,15-dihydroxy-3-methoxy-29-methyl-23,30-bis(methylene)-, (2R,3R,3aS,7R,10S,11R,12S,13S,14S,15S,16R,21S,24S,27S,29R,31R,32aS)


  • Catalogue No.:PA 05 1811001

  • CAS :

    1534341-96-2

  • Molecular Formula : C40H61NO12

  • Molecular Weight : 747.92

Drug Reference Standards & Impurity Synthesis in India
PA 05 1811002

(1R,2S,3S,4S,5S,6R,11S,14S,17S,19R,21R,23S,25R,26R,27S,31R,34S)-25-[(2S)-3-Amino-2-hydroxypropyl]-2,5-dihydroxy-26-methoxy-19-methyl-13,20-dimethylidene-24,35,36,37,38,39-hexaoxaheptacyclo[29.3.1.13,6.14,34.111,14.117,21.023,27]nonatriacontane-8,29-dione

(1R,2S,3S,4S,5S,6R,11S,14S,17S,19R,21R,23S,25R,26R,27S,31R,34S)-25-[(2S)-3-Amino-2-hydroxypropyl]-2,5-dihydroxy-26-methoxy-19-methyl-13,20-dimethylidene-24,35,36,37,38,39-hexaoxaheptacyclo[29.3.1.13,6.14,34.111,14.117,21.023,27]nonatriacontane-8,29-dione


  • Catalogue No.:PA 05 1811002

  • CAS :

    NA

  • Molecular Formula : C40H61NO12

  • Molecular Weight : 747.92

Drug Reference Standards & Impurity Synthesis in India
PA 05 1811003

Eribulin Impurity 1

Eribulin Impurity 1


  • Catalogue No.:PA 05 1811003

  • CAS :

    NA

  • Molecular Formula : C40H61NO12

  • Molecular Weight : 747.92

Drug Reference Standards & Impurity Synthesis in India
PA 05 1811004

(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2R)-3-Amino-2-hydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one

(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2R)-3-Amino-2-hydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one


  • Catalogue No.:PA 05 1811004

  • CAS :

    1190091-21-4

  • Molecular Formula : C40H59NO11

  • Molecular Weight : 729.91

Drug Reference Standards & Impurity Synthesis in India
PA 05 1811005

(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2S)-2,3-Dihydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2?,3?:5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one

(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2S)-2,3-Dihydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2?,3?:5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one


  • Catalogue No.:PA 05 1811005

  • CAS :

    253128-15-3

  • Molecular Formula : C40H58O12

  • Molecular Weight : 730.89

pharmaffiliates